NCT02356159 2025-09-30Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell TransplantationNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed34 enrolled 18 charts